Author
Verily Life Sciences LLC (United States)ORCID 0000-0002-6407-8646Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Eric Venner, Karynne Patterson, Divya Kalra…·May Okihiro
The paper analyzes pathogenic variant frequencies in the All of Us cohort by ancestry, revealing disparities and potential biases in genomic data.
Srinivas Niranj Chandrasekaran, Jeanelle Ackerman, Eric Alix…·Anne Elizabeth Carpenter
Cell Painting images and profiles for 115,796 compounds in U2OS cells from 12 laboratories; 15.2% of analyzed compounds are phenotypically active, and cross-laboratory replicates cut reference-compound activity by 34%.
Nicole A. Deflaux, Margaret Sunitha Selvaraj, Henry Robert Condon…·Alexander G. Bick
This study compares meta-analysis and pooled analysis approaches in cross-cohort GWAS of lipid measures, finding method-specific variants and implications for TRE design and analysis.